Screener
Catalyst Biosciences CBIO Q1 2026 earnings
Reported April 29, 2026 · After market close
Revenue$1.0MBeat by $642.9K
EPS-$0.70Beat by $0.15
Revenue estimate$357.1K
EPS estimate-$0.85
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Catalyst Biosciences report Q1 2026 earnings?
- Catalyst Biosciences (CBIO) reported Q1 2026 earnings on April 29, 2026 after market close.
- What were Catalyst Biosciences's Q1 2026 revenue and EPS?
- Catalyst Biosciences reported revenue of $1.0M and eps of $-0.70 for Q1 2026.
- Did Catalyst Biosciences beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $357.1K by $642.9K. EPS beat the consensus estimate of $-0.85 by $0.15.
- How did Catalyst Biosciences's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 1650.0% from $-0.04.
- Where can I find Catalyst Biosciences's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-028386) and the 10-Q periodic report (0001628280-26-028362) directly on SEC EDGAR. The filing index links above go to sec.gov.
